Skip to content
AnalystLens

Gartner Quarterly Report for Q3 Ended Sep 30, 2024

Filing Date
Filed November 5, 2024
Period End
September 30, 2024
Security
IT
In the record · 2016–202610-K1210-Q338-K108

IT filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 108 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Apr ’17Apr ’17
  2. Material agreement8-K · Jun ’20Jun ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 10-Q filed November 5, 2024. Cited figures are marked; the original filing is the authoritative source.

Gartner, Inc. (NYSE: IT) reported third-quarter 2024 total revenues of $1,484.3 milliona, up 5% from $1,408.8 million in the third quarter of 2023, with net income of $415.0 million versus $180.0 million a year earlier and diluted EPS of $5.32 versus $2.26.

The quarter's results were materially lifted by a $300.0 millionb gain on event cancellation insurance claims, recognized after a July 25, 2024 settlement resolving all remaining 2020 and 2021 claims. Operating income was essentially flat at $245.8 million versus $244.4 million, as higher cost of services and SG&A expenses offset revenue growth. Research revenue rose 5% to $1,280.9 million, Conferences revenue rose 32% to $75.8 million, and Consulting revenue fell 4% to $127.6 million.

Research contract value reached $5.04 billionc at September 30, 2024, up 7% excluding foreign currency impact. For the nine months ended September 30, 2024, revenue was $4,552.3 million (up 5%) and net income was $855.1 million (up 27%), while operating income declined 10% to $838.5 million because the prior-year period included a $135.4 million gain on the sale of TalentNeuron. Cash provided by operating activities rose to $1,149.6 million from $931.4 million, helped by the $300.0 million insurance proceeds, and the company repurchased $633.4 million of treasury stock during the period.

Cash and cash equivalents were $1.8 billiond at quarter-end, with approximately $707.0 million of available revolver capacity under the 2024 Credit Agreement. Balance sheet leverage remains significant, with $2.5 billion of principal debt outstanding against total stockholders' equity of $1,064.7 million, up from $680.6 million at December 31, 2023.

Management stated it believes liquidity is adequate for the next twelve months and the foreseeable future. Investors should weigh the one-time insurance gain against underlying operating income, which was broadly unchanged in the quarter.

Key Highlights

  1. Q3 2024 net income of $415.0 million and diluted EPS of $5.32, versus $180.0 million and $2.26 in Q3 2023, driven primarily by a $300.0 million gain on event cancellation insurance claims.
  2. Q3 2024 total revenues of $1,484.3 million, up 5% year over year; Research up 5%, Conferences up 32%, Consulting down 4%.
  3. Q3 2024 operating income of $245.8 million, essentially flat versus $244.4 million, as SG&A rose to $711.7 million from $660.5 million.
  4. Nine-month operating income declined to $838.5 million from $935.5 million, reflecting the prior-year $135.4 million gain on the TalentNeuron sale.
  5. Research contract value rose to $5.04 billion at September 30, 2024, up 7% excluding foreign currency; Global Business Sales contract value grew 12%.
  6. Cash from operations was $1,149.6 million for nine months versus $931.4 million, with $633.4 million used for share repurchases.
  7. Total debt principal of $2.5 billion at September 30, 2024, with $1.8 billion of cash and approximately $707.0 million of revolver availability.

Follow one dollar

Of each $1.00 of revenue in Q3 FY2024, Gartner kept $0.28.

  1. Revenue$1.48B100.0%
  2. Cost of revenue−$468.9M31.6%
  3. Gross profit$1.02B68.4%
  4. Operating costs−$769.6M51.8%
  5. Operating income$245.8M16.6%
  6. Interest, other & tax$169.2M11.4%
  7. Net income$415.0M28.0%
Computed from 10-QQ3 FY2024filed November 5, 2024Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q3 FY2024 against Q3 FY2023

Line itemQ3 FY2024Q3 FY2023Change
Revenue$1.48B$1.41B+5.4%
Cost of Revenue$475.34M$450.84M+5.4%
Gross Profit$1.02B$957.94M+6.0%
SG&A Expenses$711.73M$660.53M+7.8%
Operating Expenses$1.24B$1.16B+6.4%
Operating Income$245.82M$244.42M+0.6%
Net Income$415.05M$180.01M+130.6%
EPS (Basic)$5.36$2.28+135.1%
EPS (Diluted)$5.32$2.26+135.4%
Shares Outstanding (Basic)77.48M78.92M−1.8%
Shares Outstanding (Diluted)77.97M79.52M−2.0%

Frequently Asked Questions

  1. What drove the large increase in net income this quarter?

    Net income rose to $415.0 million from $180.0 million mainly because of a $300.0 million gain on event cancellation insurance claims, recognized following a July 25, 2024 settlement. Revenue growth and lower net interest expense also contributed, partially offset by higher operating expenses.

  2. Is underlying operating performance improving?

    Operating income was $245.8 million, roughly flat with $244.4 million a year earlier. Revenue grew 5%, but cost of services and product development rose 5% and SG&A rose 8%, which absorbed most of the revenue gain.

  3. How healthy is the Research business?

    Research revenue increased 5% to $1,280.9 million in the quarter, and contract value grew 7% to $5.04 billion excluding foreign currency. Global Technology Sales client retention was 83% and Global Business Sales client retention was 87%, down from 88% a year earlier, with GBS wallet retention declining to 106% from 108%.

  4. How is the company managing its capital and debt?

    The company repurchased $633.4 million of stock in the nine months and borrowed $274.4 million under a new $1.0 billion revolving facility to refinance the 2020 Credit Agreement. Management states it believes it has adequate liquidity for the next twelve months and the foreseeable future, with $1.8 billion of cash and about $707.0 million of available revolver capacity.